Thema
Clinical Trial, Phase III
18.646
Journal Article
18.448
Randomized Controlled Trial
15.803
Research Support, Non-U.S. Gov't
11.526
Multicenter Study
10.291
Comparative Study
3.003
Antibodies, Monoclonal, Humanized
1.940
Research Support, N.I.H., Extramural
1.664
Antineoplastic Agents
1.296
Clinical Trial, Phase II
1.205
EC 2.7.10.1
1.000
Antibodies, Monoclonal
972
Fluorouracil
761
U3P01618RT
760
Cisplatin
718
Q20Q21Q62J
716
Drug Combinations
629
Paclitaxel
586
P88XT4IS4D
584
Biomarkers, Tumor
530
0W860991D6
526
Deoxycytidine
526
Docetaxel
524
15H5577CQD
523
Pyrimidines
513
Hypoglycemic Agents
507
Receptor, ErbB-2
490
Placebos
485
Antirheumatic Agents
483
Cyclophosphamide
444
Protein Kinase Inhibitors
444
8N3DW7272P
443
Carboplatin
442
BG3F62OND5
440
Bevacizumab
439
2S9ZZM9Q9V
437
Biomarkers
437
Taxoids
436
Antiviral Agents
410
Antibodies, Viral
402
Glycated Hemoglobin A
391
Blood Glucose
390
Recombinant Proteins
386
Sulfonamides
379
80168379AG
377
Doxorubicin
377
Anti-Bacterial Agents
361
Methotrexate
356
YL5FZ2Y5U1
356
Gemcitabine
349
mehr ...